Timothy K. Andrews

All filings by Timothy K. Andrews on record concern Sienna Biopharmaceuticals, Inc. In total, 4 filings cover trades dated from 1 August 2017 to 6 August 2019.

The open-market record is one-sided, with 1 purchase worth €190k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants.

The latest filing, published on 8 August 2019, reports a share grant in Sienna Biopharmaceuticals, Inc. The most recent open-market purchase was published on 1 August 2017, 3,368 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.